Literature DB >> 17574851

Synthesis and matrix metalloproteinase (MMP)-12 inhibitory activity of ageladine A and its analogs.

Naoki Ando1, Shiro Terashima.   

Abstract

Ageladine A (1) and its analogs 2-10 were expeditiously synthesized by featuring the biosynthetic route proposed for 1 (for 1-10) and by employing 2-(N-t-butoxycarbonylamino)imidazol-4-carbaldehyde as the starting material (for 1-8). From MMP-12 inhibitory activity assay, it appeared evident that the two bromine atoms and the three NH groups (1-NH, 14-NH, and 15-NH2) were indispensable for 1 to exhibit excellent activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17574851     DOI: 10.1016/j.bmcl.2007.06.005

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  Synthesis and anticancer activities of ageladine A and structural analogs.

Authors:  Yuelong Ma; Sangkil Nam; Richard Jove; Kenichi Yakushijin; David A Horne
Journal:  Bioorg Med Chem Lett       Date:  2009-11-14       Impact factor: 2.823

2.  The chemically synthesized ageladine A-derivative LysoGlow84 stains lysosomes in viable mammalian brain cells and specific structures in the marine flatworm Macrostomum lignano.

Authors:  Thorsten Mordhorst; Sushil Awal; Sebastian Jordan; Charlotte Petters; Linda Sartoris; Ralf Dringen; Ulf Bickmeyer
Journal:  Mar Drugs       Date:  2015-02-11       Impact factor: 5.118

Review 3.  Pharmacological Potential and Synthetic Approaches of Imidazo[4,5-b]pyridine and Imidazo[4,5-c]pyridine Derivatives.

Authors:  Malwina Krause; Henryk Foks; Katarzyna Gobis
Journal:  Molecules       Date:  2017-03-04       Impact factor: 4.411

Review 4.  A submarine journey: the pyrrole-imidazole alkaloids.

Authors:  Barbara Forte; Beatrice Malgesini; Claudia Piutti; Francesca Quartieri; Alessandra Scolaro; Gianluca Papeo
Journal:  Mar Drugs       Date:  2009-11-27       Impact factor: 5.118

Review 5.  Marine-derived angiogenesis inhibitors for cancer therapy.

Authors:  Ying-Qing Wang; Ze-Hong Miao
Journal:  Mar Drugs       Date:  2013-03-15       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.